South Korea Pharmaceutical Drug Delivery Market Report by Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery, Nasal Drug Delivery), Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Others), End User (Hospitals, Ambulatory Surgery Centers, Home Care Settings, Diagnostic Centers, and Others), and Region 2026-2034
The South Korea pharmaceutical drug delivery market size reached USD 30.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 59.2 Billion by 2034, exhibiting a growth rate (CAGR) of 7.61% during 2026-2034. The rising healthcare expenditure, growing pharmaceutical industry, increasing chronic diseases, patient-centric care, successful collaborations and partnerships, rapidly increasing aging population, and growth of the medical tourism across the region represent some of the key factors driving the market.
Pharmaceutical drug delivery refers to the process of administering medication to patients in a safe and effective manner. It plays a crucial role in the field of healthcare by ensuring that drugs are delivered to the right place in the body, at the right time, and in the right dosage. This optimization is essential to maximize the therapeutic benefits of pharmaceuticals while minimizing potential side effects. One of the primary objectives of drug delivery is to enhance the bioavailability of drugs. Bioavailability refers to the extent and rate at which a drug reaches its target site in the body and becomes available to produce its therapeutic effect. Various factors can impact bioavailability, including the drug's chemical properties, formulation, and the method of administration. Drug delivery technologies are designed to overcome these challenges and improve the overall efficiency of drug delivery.
SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET TRENDS:
South Korea has been witnessing a consistent increase in healthcare expenditure, driven by factors such as an aging population, increased healthcare awareness, and higher income levels. As healthcare spending grows, there is a greater emphasis on improving drug delivery methods to enhance the overall efficacy of treatments. Additionally, the region has a robust pharmaceutical industry that is rapidly expanding. With a focus on research and development, pharmaceutical companies are increasingly investing in innovative drug delivery technologies to gain a competitive edge. This contributes significantly to the development and adoption of advanced drug delivery systems. Other than this, the prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders is on the rise in South Korea. These conditions often require long-term medication, making patient-friendly drug delivery systems crucial. This drives the demand for innovations that enhance drug effectiveness and patient adherence. Besides this, healthcare in South Korea is increasingly moving toward a patient-centric approach. Drug delivery systems that offer convenience, reduce pain, and improve the overall patient experience are highly sought after. This trend is pushing companies to develop user-friendly drug delivery solutions. In line with this, collaboration between pharmaceutical companies, research institutions, and academia is fostering innovation in drug delivery. Partnerships with global pharmaceutical giants and local startups are driving research and development efforts to create novel delivery systems. Furthermore, South Korea is known for its technological prowess. The integration of cutting-edge technologies, such as nanotechnology and biotechnology, into drug delivery systems has opened up new possibilities. These advancements allow for more precise drug targeting, controlled release, and reduced side effects. Moreover, the South Korean government plays a pivotal role in shaping the pharmaceutical and healthcare landscape. Regulatory agencies, like the Ministry of Food and Drug Safety (MFDS), have been promoting the use of novel drug delivery systems that improve patient compliance and treatment outcomes. Government support through funding and incentives for research and development further accelerates innovation in this sector.
SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2026-2034. Our report has categorized the market based on route of administration, application, and end user.
Route of Administration Insights:
Application Insights:
End User Insights:
Regional Insights:
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea pharmaceutical drug delivery market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea pharmaceutical drug delivery market?
What is the breakup of the South Korea pharmaceutical drug delivery market on the basis of route of administration?
What is the breakup of the South Korea pharmaceutical drug delivery market on the basis of application?
What is the breakup of the South Korea pharmaceutical drug delivery market on the basis of end user?
What are the various stages in the value chain of the South Korea pharmaceutical drug delivery market?
What are the key driving factors and challenges in the South Korea pharmaceutical drug delivery?
What is the structure of the South Korea pharmaceutical drug delivery market and who are the key players?
What is the degree of competition in the South Korea pharmaceutical drug delivery market?
Pharmaceutical drug delivery refers to the process of administering medication to patients in a safe and effective manner. It plays a crucial role in the field of healthcare by ensuring that drugs are delivered to the right place in the body, at the right time, and in the right dosage. This optimization is essential to maximize the therapeutic benefits of pharmaceuticals while minimizing potential side effects. One of the primary objectives of drug delivery is to enhance the bioavailability of drugs. Bioavailability refers to the extent and rate at which a drug reaches its target site in the body and becomes available to produce its therapeutic effect. Various factors can impact bioavailability, including the drug's chemical properties, formulation, and the method of administration. Drug delivery technologies are designed to overcome these challenges and improve the overall efficiency of drug delivery.
SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET TRENDS:
South Korea has been witnessing a consistent increase in healthcare expenditure, driven by factors such as an aging population, increased healthcare awareness, and higher income levels. As healthcare spending grows, there is a greater emphasis on improving drug delivery methods to enhance the overall efficacy of treatments. Additionally, the region has a robust pharmaceutical industry that is rapidly expanding. With a focus on research and development, pharmaceutical companies are increasingly investing in innovative drug delivery technologies to gain a competitive edge. This contributes significantly to the development and adoption of advanced drug delivery systems. Other than this, the prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders is on the rise in South Korea. These conditions often require long-term medication, making patient-friendly drug delivery systems crucial. This drives the demand for innovations that enhance drug effectiveness and patient adherence. Besides this, healthcare in South Korea is increasingly moving toward a patient-centric approach. Drug delivery systems that offer convenience, reduce pain, and improve the overall patient experience are highly sought after. This trend is pushing companies to develop user-friendly drug delivery solutions. In line with this, collaboration between pharmaceutical companies, research institutions, and academia is fostering innovation in drug delivery. Partnerships with global pharmaceutical giants and local startups are driving research and development efforts to create novel delivery systems. Furthermore, South Korea is known for its technological prowess. The integration of cutting-edge technologies, such as nanotechnology and biotechnology, into drug delivery systems has opened up new possibilities. These advancements allow for more precise drug targeting, controlled release, and reduced side effects. Moreover, the South Korean government plays a pivotal role in shaping the pharmaceutical and healthcare landscape. Regulatory agencies, like the Ministry of Food and Drug Safety (MFDS), have been promoting the use of novel drug delivery systems that improve patient compliance and treatment outcomes. Government support through funding and incentives for research and development further accelerates innovation in this sector.
SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2026-2034. Our report has categorized the market based on route of administration, application, and end user.
Route of Administration Insights:
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Implantable Drug Delivery
- Transmucosal Drug Delivery
- Nasal Drug Delivery
Application Insights:
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Others
End User Insights:
- Hospitals
- Ambulatory Surgery Centers
- Home Care Settings
- Diagnostic Centers
- Others
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
- Others
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea pharmaceutical drug delivery market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea pharmaceutical drug delivery market?
What is the breakup of the South Korea pharmaceutical drug delivery market on the basis of route of administration?
What is the breakup of the South Korea pharmaceutical drug delivery market on the basis of application?
What is the breakup of the South Korea pharmaceutical drug delivery market on the basis of end user?
What are the various stages in the value chain of the South Korea pharmaceutical drug delivery market?
What are the key driving factors and challenges in the South Korea pharmaceutical drug delivery?
What is the structure of the South Korea pharmaceutical drug delivery market and who are the key players?
What is the degree of competition in the South Korea pharmaceutical drug delivery market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (?2026-2034)
6 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET - BREAKUP BY ROUTE OF ADMINISTRATION
6.1 Oral Drug Delivery
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (?2026-2034)
6.2 Injectable Drug Delivery
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (?2026-2034)
6.3 Topical Drug Delivery
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (?2026-2034)
6.4 Ocular Drug Delivery
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2020-2025)
6.4.3 Market Forecast (?2026-2034)
6.5 Pulmonary Drug Delivery
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2020-2025)
6.5.3 Market Forecast (?2026-2034)
6.6 Implantable Drug Delivery
6.6.1 Overview
6.6.2 Historical and Current Market Trends (2020-2025)
6.6.3 Market Forecast (?2026-2034)
6.7 Transmucosal Drug Delivery
6.7.1 Overview
6.7.2 Historical and Current Market Trends (2020-2025)
6.7.3 Market Forecast (?2026-2034)
6.8 Nasal Drug Delivery
6.8.1 Overview
6.8.2 Historical and Current Market Trends (2020-2025)
6.8.3 Market Forecast (?2026-2034)
7 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET - BREAKUP BY APPLICATION
7.1 Infectious Diseases
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (?2026-2034)
7.2 Cancer
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (?2026-2034)
7.3 Cardiovascular Diseases
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Forecast (?2026-2034)
7.4 Diabetes
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2020-2025)
7.4.3 Market Forecast (?2026-2034)
7.5 Respiratory Diseases
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2020-2025)
7.5.3 Market Forecast (?2026-2034)
7.6 Central Nervous System Disorders
7.6.1 Overview
7.6.2 Historical and Current Market Trends (2020-2025)
7.6.3 Market Forecast (?2026-2034)
7.7 Autoimmune Diseases
7.7.1 Overview
7.7.2 Historical and Current Market Trends (2020-2025)
7.7.3 Market Forecast (?2026-2034)
7.8 Others
7.8.1 Historical and Current Market Trends (2020-2025)
7.8.2 Market Forecast (?2026-2034)
8 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET - BREAKUP BY END USER
8.1 Hospitals
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (?2026-2034)
8.2 Ambulatory Surgery Centers
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (?2026-2034)
8.3 Home Care Settings
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (?2026-2034)
8.4 Diagnostic Centers
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (?2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (?2026-2034)
9 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET – BREAKUP BY REGION
9.1 Seoul Capital Area
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Breakup by Route of Administration
9.1.4 Market Breakup by Application
9.1.5 Market Breakup by End User
9.1.6 Key Players
9.1.7 Market Forecast (?2026-2034)
9.2 Yeongnam (Southeastern Region)
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Breakup by Route of Administration
9.2.4 Market Breakup by Application
9.2.5 Market Breakup by End User
9.2.6 Key Players
9.2.7 Market Forecast (?2026-2034)
9.3 Honam (Southwestern Region)
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2020-2025)
9.3.3 Market Breakup by Route of Administration
9.3.4 Market Breakup by Application
9.3.5 Market Breakup by End User
9.3.6 Key Players
9.3.7 Market Forecast (?2026-2034)
9.4 Hoseo (Central Region)
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2020-2025)
9.4.3 Market Breakup by Route of Administration
9.4.4 Market Breakup by Application
9.4.5 Market Breakup by End User
9.4.6 Key Players
9.4.7 Market Forecast (?2026-2034)
9.5 Others
9.5.1 Historical and Current Market Trends (2020-2025)
9.5.2 Market Forecast (?2026-2034)
10 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET – COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant
11 PROFILES OF KEY PLAYERS
11.1 Company A
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Business Strategies
11.1.4 SWOT Analysis
11.1.5 Major News and Events
11.2 Company B
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Business Strategies
11.2.4 SWOT Analysis
11.2.5 Major News and Events
11.3 Company C
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Business Strategies
11.3.4 SWOT Analysis
11.3.5 Major News and Events
11.4 Company D
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Business Strategies
11.4.4 SWOT Analysis
11.4.5 Major News and Events
11.5 Company E
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Business Strategies
11.5.4 SWOT Analysis
11.5.5 Major News and Events
12 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET - INDUSTRY ANALYSIS
12.1 Drivers, Restraints, and Opportunities
12.1.1 Overview
12.1.2 Drivers
12.1.3 Restraints
12.1.4 Opportunities
12.2 Porters Five Forces Analysis
12.2.1 Overview
12.2.2 Bargaining Power of Buyers
12.2.3 Bargaining Power of Suppliers
12.2.4 Degree of Competition
12.2.5 Threat of New Entrants
12.2.6 Threat of Substitutes
12.3 Value Chain Analysis
13 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (?2026-2034)
6 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET - BREAKUP BY ROUTE OF ADMINISTRATION
6.1 Oral Drug Delivery
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (?2026-2034)
6.2 Injectable Drug Delivery
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (?2026-2034)
6.3 Topical Drug Delivery
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (?2026-2034)
6.4 Ocular Drug Delivery
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2020-2025)
6.4.3 Market Forecast (?2026-2034)
6.5 Pulmonary Drug Delivery
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2020-2025)
6.5.3 Market Forecast (?2026-2034)
6.6 Implantable Drug Delivery
6.6.1 Overview
6.6.2 Historical and Current Market Trends (2020-2025)
6.6.3 Market Forecast (?2026-2034)
6.7 Transmucosal Drug Delivery
6.7.1 Overview
6.7.2 Historical and Current Market Trends (2020-2025)
6.7.3 Market Forecast (?2026-2034)
6.8 Nasal Drug Delivery
6.8.1 Overview
6.8.2 Historical and Current Market Trends (2020-2025)
6.8.3 Market Forecast (?2026-2034)
7 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET - BREAKUP BY APPLICATION
7.1 Infectious Diseases
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (?2026-2034)
7.2 Cancer
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (?2026-2034)
7.3 Cardiovascular Diseases
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Forecast (?2026-2034)
7.4 Diabetes
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2020-2025)
7.4.3 Market Forecast (?2026-2034)
7.5 Respiratory Diseases
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2020-2025)
7.5.3 Market Forecast (?2026-2034)
7.6 Central Nervous System Disorders
7.6.1 Overview
7.6.2 Historical and Current Market Trends (2020-2025)
7.6.3 Market Forecast (?2026-2034)
7.7 Autoimmune Diseases
7.7.1 Overview
7.7.2 Historical and Current Market Trends (2020-2025)
7.7.3 Market Forecast (?2026-2034)
7.8 Others
7.8.1 Historical and Current Market Trends (2020-2025)
7.8.2 Market Forecast (?2026-2034)
8 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET - BREAKUP BY END USER
8.1 Hospitals
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (?2026-2034)
8.2 Ambulatory Surgery Centers
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (?2026-2034)
8.3 Home Care Settings
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (?2026-2034)
8.4 Diagnostic Centers
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (?2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (?2026-2034)
9 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET – BREAKUP BY REGION
9.1 Seoul Capital Area
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Breakup by Route of Administration
9.1.4 Market Breakup by Application
9.1.5 Market Breakup by End User
9.1.6 Key Players
9.1.7 Market Forecast (?2026-2034)
9.2 Yeongnam (Southeastern Region)
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Breakup by Route of Administration
9.2.4 Market Breakup by Application
9.2.5 Market Breakup by End User
9.2.6 Key Players
9.2.7 Market Forecast (?2026-2034)
9.3 Honam (Southwestern Region)
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2020-2025)
9.3.3 Market Breakup by Route of Administration
9.3.4 Market Breakup by Application
9.3.5 Market Breakup by End User
9.3.6 Key Players
9.3.7 Market Forecast (?2026-2034)
9.4 Hoseo (Central Region)
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2020-2025)
9.4.3 Market Breakup by Route of Administration
9.4.4 Market Breakup by Application
9.4.5 Market Breakup by End User
9.4.6 Key Players
9.4.7 Market Forecast (?2026-2034)
9.5 Others
9.5.1 Historical and Current Market Trends (2020-2025)
9.5.2 Market Forecast (?2026-2034)
10 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET – COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant
11 PROFILES OF KEY PLAYERS
11.1 Company A
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Business Strategies
11.1.4 SWOT Analysis
11.1.5 Major News and Events
11.2 Company B
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Business Strategies
11.2.4 SWOT Analysis
11.2.5 Major News and Events
11.3 Company C
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Business Strategies
11.3.4 SWOT Analysis
11.3.5 Major News and Events
11.4 Company D
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Business Strategies
11.4.4 SWOT Analysis
11.4.5 Major News and Events
11.5 Company E
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Business Strategies
11.5.4 SWOT Analysis
11.5.5 Major News and Events
12 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET - INDUSTRY ANALYSIS
12.1 Drivers, Restraints, and Opportunities
12.1.1 Overview
12.1.2 Drivers
12.1.3 Restraints
12.1.4 Opportunities
12.2 Porters Five Forces Analysis
12.2.1 Overview
12.2.2 Bargaining Power of Buyers
12.2.3 Bargaining Power of Suppliers
12.2.4 Degree of Competition
12.2.5 Threat of New Entrants
12.2.6 Threat of Substitutes
12.3 Value Chain Analysis
13 APPENDIX
